throbber
Thalassemia Intermedia, with Iron Overload,
`Cardiac Failure, Diabetes Mellitus,
`Hypopituitarism and Porphyrinuria*
`
`RoBIN M. BANNERMAN, D.M., GERALD KEuscH, M.D., t MARTHA KREIMER-BIRNBAUM, PH.D. ,
`VERNON K. VANCE, M.D. and STUART VAUGHAN, M.D., PH.D.
`Buffalo, New York
`
`A patient of Sicilian ancestry who had thalassemia intermedia was seen intermittently
`from the time he was six to forty-one years of age. He had inherited at least one allele
`for the "high hemoglobin F, normal hemoglobin A2" type of 13-thalassemia. Splenec(cid:173)
`tomy had been carried out during his childhood; he was also given iron medication
`orally and deliberately ate iron-rich foods. Although he had had only 6 units of blood
`by transfusion, by the age of forty-one severe iron overload had developed, with the
`clinical picture of hemochromatosis, including skin pigmentation, liver disease,
`cardiac failure and multiple endocrine deficiencies. Desferrioxamine was used to
`demonstrate the degree of iron load and in an attempt to reduce it. The anemia was
`further complicated by folic acid deficiency and improved with folic acid therapy.
`Porphyrinuria and urinary excretion of d ipyrroles were additional features, probably
`due to the severe degree of ineffective erythropoiesis. The pathologic mechanisms
`underlying these various complications are discussed. The danger of administering
`iron orally to such patients is emphasized.
`
`T HALASSEMIA intermedia is a useful phrase to
`
`describe a c linical form of intermediate
`severity. It may represent homozygous thalas(cid:173)
`semia in mild form or be a particularly severe
`expression of the heterozygous state. It is an
`appropriate diagnosis for the patient described
`herein. As indicated in the title, the complica(cid:173)
`tions in this patient included cardiac failure,
`diabetes mellitus and hypopituitarism, as well
`as hepatic dysfunction a ll presumed
`to be
`secondary to iron overload.
`Iron overload in thalassemia was first recog(cid:173)
`nized by Whipple and Bradford [7] and indeed
`Cooley's anemia has been referred to as "hemo(cid:173)
`chromatosis in the child" [2]. Such complica(cid:173)
`tions have become increasingly common in
`severe thalassemiia major in childhood since
`survival is prolonged by blood transfusion and
`antibiotic therapy, and intractable cardiac fail(cid:173)
`ure is now a familiar terminal event [3-5].
`
`Endocrine complications are less well docu(cid:173)
`mented. I t is of particular interest that the
`patient here described received very few blood
`transfusions and his iron overload therefore
`must h ave been acquired by intestinal absorp(cid:173)
`tion. Marked porphyrinuria was an additional
`feature in this case, and the urine also con(cid:173)
`sistently contained another brown pigment,
`probably a dipyrrole.
`
`CASE REPORT
`A forty-one year old man of Sicilian ancestry was
`admitted to the Buffalo Veterans Administration
`Hospital in December 1964 with the chief com(cid:173)
`plaints of increasing shortness of breath and swell(cid:173)
`ing of the legs for two months.
`His first hospital admission was in 1930 at the age
`of six years, when he entered a pediatric hospital be(cid:173)
`cause of "adenoids and large tonsils." It was recorded
`that birth and development up to the age of one year
`had been normal. Thereafter, he had been "chroni-
`
`* From the Department of Medicine, State University of New York at Buffalo, Buffalo Veterans Administration
`Hospital and Buffalo General Hospital, Buffalo, New York. This work was supported by U.S.P.H.S. Grant AM 05581
`and grants from the United Health Foundation of Western New York. M anuscript received June 7, 1966.
`t Present
`address: SEAT O Medical Research Laboratory, United States Army Component, APO San
`Francisco 96346.
`
`476
`
`AMER I CAN J 0 URN AL 0 F MED I C IN E
`
`
`1 of 11
`
`Taro Pharmaceuticals, Ltd.
`Exhibit 1016
`
`

`

`Thalassemia Intermedia- Bannerman el al.
`
`477
`
`TABl..E I
`HEMATOLOGIC DAT A
`
`Red Blood Cells
`x 1()1
`{per cu. mm.)
`
`Hemoglobin
`(gm./100 ml.)
`
`Hem:ltocrit Platelets X I 03
`<%>
`(per cu. mm. )
`
`Rcticulocvks
`<%).
`
`4.59
`4.23
`5 . 15
`4.03
`3.50
`4.25
`3.22
`4.10
`4.10
`
`3.70
`
`7 .6
`10.9
`12. 1
`8 .9
`10.9
`12.9
`9.4
`10. 7
`9.3
`6.0
`10.0
`
`164
`112
`266
`620
`547
`
`383
`620
`
`-~ . {)
`I 2
`
`; . 2
`
`4 0
`3. 7
`
`31
`39
`
`20
`33
`
`Datt>
`- --·----
`1?30
`1')31
`1931
`1932
`1933
`1940
`1945
`1?50
`1960
`1964t
`1965t
`
`Age
`(yr.)
`
`6
`7
`7•
`8
`9
`17
`22
`27
`37
`41
`41
`
`•After splcncctomy.
`t December.
`t July.
`
`cally run down" and was unable to keep up with other
`boys at play. Dark-colored morning urine had been
`noted. He was described as listless and icteric, ap(cid:173)
`peared to be poorly nourished, and the spleen was
`enlarged to the level of the umbilicus. Laboratory
`data are reported in Table 1. Although the records
`are incomplete, marked anisocytosis and poikilocytosis
`of the erythrocytes were reported and fragility studies
`showed increased osmotic resistance. Normoblasts
`comprised 10 per cent of the total nucleated cell
`count. The urine was negative for bile and urobilino(cid:173)
`gen. On discharge, ferric ammonium citrate (12 cc.
`of 10 per cent solution, three times a day) and copper
`sulfate were prescribed and he continued to take the
`iron mixture for an unknown, but possibly prolonged
`period.
`The patient was next seen in 1931 because of
`anorexia, nausea, vomiting, abdominal distention
`and jaundice. The icterus index was 75 and he was
`am·mie. The diagnosis of "an atypical type of con(cid:173)
`genital hemolytic anemia" was made and splenectomy
`was performed. He received 6 units of blood by trans(cid:173)
`fusion during surgery. This was his first and only blood
`transfusion until the age of forty-one. The spleen was
`desc ribed as "a chronic splenic tumor in some respects
`resembling the picture of so-called Banti spleen, dif(cid:173)
`fering from that in a smaller amount of fibrosis of
`stroma." After splenectomy the red blood cell a nd
`platl'iet counts increased and normoblasts rose to
`47 per cent of the total nucleated cells.
`The patient was first seen by one of us (S.V.) in
`19 32 and the diagnosis of Cooley's anemia was made.
`In 1933 he was "feeling pretty well" and attending
`school regularly, but experiencing periodic attacks
`about one week in duration during which marked
`apathy occurred, associated with yellow coloring of
`the skin.
`
`VOi.. 42, MARCH 1967
`
`In 1940 at the age of seventeen, the patient was in
`his third year of high school and participating ac(cid:173)
`tively in sports. In a phot0graph taken about chat
`time his features were normal, with no suggestion of
`the mongoloid facics, prognathism or malocclusion
`which are see n in childhood Cooley's anemia. It was
`noted that at times there was faint scleral icterus and
`that the liver was palpable. Pubic hair was scanty.
`with a female distribution. Oral administration of
`iron had definitely been di5continued by this time.
`but ic wa~ uncertain whether the patient had been
`taking iron consistently over the previous ten years.
`However, he continued to eat large quantities of
`iron-rich foods, such as liver and spinach.
`In September 1944 the patient was inducted into
`the U.S. Army. On physical examination at induction
`the splenectomy scar was the only abnormality re(cid:173)
`ported. The liver was not palpable. During che four(cid:173)
`teen weeks of basic training he had sharp pain in the
`lower part of the abdomen associated with exercise,
`particularly long hikes. Because of this complaint and
`a "cold" he was admitted to an Army hospital in
`January 1945. He was slightly jaundiced and again
`no hcpatomegaly was noted. Blood examination on
`admission revealed anemia (Table 1) with aniso(cid:173)
`cytosis, poilcilocytosis, polychromasia and target cells
`in the blood film and increased osmotic resistance
`of the erythrocytes. The icterus index was 19 and the
`serum bilirubin was 1.8 mg. per 100 ml. Roentgeno(cid:173)
`grams of the skull were reported as showing slight
`thickening of the diploe with thinning of the inner
`and outer tables. The long bones were roentgeno(cid:173)
`logically normal. Because of the diagnosis of Cooley's
`anemia, he received an honorable discharge from the
`service.
`The patient was next seen i n 1950. The blood film
`showed
`target cells, with many orthochromatic
`
`
`2 of 11
`
`Taro Pharmaceuticals, Ltd.
`Exhibit 1016
`
`

`

`478
`
`Thalassemia Intermedia-Bannerman et al.
`
`2
`
`Fro. 1. Patient J .G., sh owing diffuse and mottled facial p igmentation and youthful
`appearance.
`
`FIG. 2. Patient J .G. on atlmissiuu Lu husµiLal iu Dcccmucr 1964, with cardiac failure and
`severe edema. Sparse body hair and splenectomy scar can also be seen.
`
`normoblasts and increased numbers of platelets with
`many gia nt forms. Aspiration of the bone marrow
`revealed a very cellular marrow with a tremendous
`increase in erythropoiesis. The myeloid: erythroid
`ratio was 0.2.
`In 1960, while living in California, he was seen at a
`hospital because of discomfort in the lower right quad(cid:173)
`rant of the abdomen. His skin \.vas reported to be
`sla te gray in color, there was scleral icterus, and the
`liver edge was firm and palpable at the iliac crest. He
`was found to be anemic and the blood film showed
`target cells and many
`macrocytes, microcytes,
`nucleated red cells. The serum bilirubin was 2.5 mg.
`per 100 ml. with 2.3 mg. indirect reacting. The
`serum total protein was 7.3 gm. per 100 ml., albumin
`3.1 and globulin 4 .2 gm. per 100 ml. The serum
`alkaline phosphatase was 22 King-Armstrong units,
`prothrombin time was 20 per cent of normal, and the
`thymol turbidity was 7.6 units. Serum iron was 299
`µg. per 100 ml. and the total iron-binding capacity
`was 595 µg. per 100 ml. The tentative diagnosis of
`thalassemia intermedia with secondary hemochroma-
`
`tosis was made and liver biopsy was advised, but
`refused.
`Since that time the patient noticed gradually in(cid:173)
`creasing darkening of the skin and, for one year, loss
`of libido and thinning of the axillary and pubic hair.
`Swelling of the legs started two months before admis(cid:173)
`sion and increased rapidly. For the month before
`admission he experienced nocturia, increased sweating
`and dyspnea on exertion, and orthopnea developed.
`He complained of vague discomfort in the lower part
`of the abdomen, particularly at night, and periodic
`"spasms" of the calf muscles and hands which were
`relieved by massage. There was no history of al(cid:173)
`coholism.
`On examination, the patient was a thin, ill-looking
`man with remarkably intense brown-gray color of
`the skin, particularly of the exposed areas. The dis(cid:173)
`tribution of the pigmentation was somewhat irregular
`with a mottled appearance (Fig. 1) and his features
`were lean and aquiline. H e looked younger than his
`chronologic age. Facial and body hair were very
`sparse, with female distribution of pubic hair (Fig.
`
`AMER I CAN J OURNAL O F MED I CINE
`
`
`3 of 11
`
`Taro Pharmaceuticals, Ltd.
`Exhibit 1016
`
`

`

`Thalassemia Intermedia-Bannerman el al.
`
`479
`
`Fm. 3. Blood film with very marked anisocytosis and poikilocytosis, hypochromia and
`target cells, inclusion bodies (Howell-Jolly bodies and iron granule~ }. cellular fr:i~ments
`and normoblasts. Wright's stain, original magnification X 1,350.
`
`2). There was scleral iCLcrus, and sli t-lamp examina(cid:173)
`tio n revealed bilateral early subcapsular cataracts.
`The patient was very breathless. The pulse rate was
`120 per minute and the blood pressure 120/ 70 mm.
`Hg. The heart was enlarged, a left ventricular heave
`was palpated, and a gallop rhythm and a grade 2/ 6
`ejection systolic murmur were heard at the left
`sternal border. The jugular venous pressure was
`raised, and there were signs of a right-sided pleural
`effusion. The liver was very large, extending to
`below the umbilicus in the midline, and an enlarged
`Riedel's lobe extended to the right iliac crest. There
`was a left paramedian scar from previous splenectom y.
`The testes were small and soft. There was slight ascites
`and severe pitting edema of the legs extending into
`the penis and scrotum (Fig. 2).
`The hemoglobin was 6 gm. per 100 ml., hematocrit
`20 per cent and reticulocyte count 4 per cent. Of the
`nucleated cells, 71 per cent were normoblasts, and the
`corrected white cell count was 13,000 per cu. mm.,
`with a normal differential except for 3 per cem
`eosioophils. The direct total eosinophil count was
`782 per cu. mm. The blood film showed marked aniso(cid:173)
`cytosis and poikilocytosis with hypochromia and
`occasional target cells (Fig. 3), and staining for iron
`(6 J revealed many siderocytes and sideroblasts.
`Staining for fe tal hemoglobin (7] demonstrated un(cid:173)
`even distribution with variation in the intensity of
`staining from cell to celJ. (Fig. 4) .
`Further hematologic data are summarized in Table
`n. Bone marrow aspiration showed erythroid hypcr-
`
`v o L. 42, MARCH 1967
`
`plasia with m<'gaioblastic changes, principally giant
`band neutrophils. The Diagncx® blue test and direct
`examination of fasting gastric juice were negative for
`free hydrochloric acid without stimulation. Scrwu
`folic acid was low; the vitamin 8 1! level was normal
`11). Hemoglobin electrophoresis did not
`(Table
`reveal any abnormal hemoglobins. Hemoglobin F
`was greatly increased [6 I and hemoglobin A2 was
`normal (Tat..Le m). The plasma hemoglotin was 57
`mg. per 100 ml.
`
`Fie. 4. Blood lilm stained by the Kleihauer and Bctke
`method [7] for fetal hemoglobin showing that it is u:(cid:173)
`regularly distributed from cell to cell and is present in
`normoblasts. Original magnification X 1,350.
`
`
`4 of 11
`
`Taro Pharmaceuticals, Ltd.
`Exhibit 1016
`
`

`

`480
`
`Thalassemia Intermedia- Bannerman et al.
`
`T ABLE II
`SPEC IAL BLOOD STUDIES
`
`TABLE lII
`HEMOGLOBIN ST UDIES IN PATIBNT AND RF.LATIV\l.S
`
`Test
`
`Results
`
`. . 135
`
`S<mm iron (µg./100 ml.). .
`S<ruw total iron-binding capacity
`(pg./ 100 ml.) . .. .. . .. . . . . .. ... . .. 150
`Plasma hemoglobin (mg./100 ml.) . . . . 57
`Pla sma haptoglobin (mg./100 ml.) ... . 15.6
`S<rum folic acid (mµg./ml.)
`On admission (12/ 64) .. . . ..... . . 4.9 (norma l range 7- 27*)
`After lapse of therapy (10/ GS) . . . .. 2.0 (norma l range 3- 271)
`S<rum vitamin B1t (µµg./ml .)
`.284 (nor!llal rang< 200-350*)
`12/ 64 . . .. . . . .
`. .. . . 987 (normal range 150-1,500 t)
`10/64. ... . . . . ... ..... .
`Scrum bilirubin (mg./100 ml.) .. ... .. 7.8 (6.1 indirect)
`Scrum total protein (gm./1 00 ml.) .
`.. 6.8 (albumin 3.1,
`globulins 3.7)
`. 21.5 (control 12.5)
`Pro thrombin 1imc (sec.) .. .
`. .. ... 85
`SG OT( units) ...
`SG PT (units) . .
`. ....... . . . . . ... .41
`LDH (units) .... . . . .. . ....... . . .. .. >2,000
`
`•Bio-Analytical LaboratoriC!, Inc., Albany, New York.
`t Courtesy of Dr. K. B. Taylor, Stanford University School of
`Medicine.
`
`The urine contained no protein or sugar, and no
`cells or casts were seen in the spun sediment. It was
`almost invariably a rich deep brown. The fasting
`blood sugar was 106 mg. per 100 ml., blood urea
`nitrogen 25 mg. per 100 ml. and creatinine 1.5 mg.
`per 100 ml. Serum sodium concentration varied from
`126 to 135 mEq. per L. and potassium from 4.3
`to 6.0 mEq. per L. Serum bilirubin was increased to
`7.8 mg. per 100 ml. with 6.1 mg. indirect reacting,
`and urinary urobilinogen was increased. Total serum
`protein was 6.8 gm. per 100 ml. with a reversal of
`the albumin: globulin ratio (3.1 : 3. 7). The one-stage
`prothrombin time was 21.5 seconds (control 12.5
`seconds). Alkaline phosphatase, serum glutamic
`oxalic (SGOT) and glutamic pyruvic transaminase
`(SGPT) levels were slightly elevated. The lactic
`dehydrogenase was increased to >2,000 units.
`A roentgenogram of the chest on admission con(cid:173)
`firmed the presence of card iac enlargement and a
`small right pleural effusion. Roentgenograms of the
`upper gastrointestinal tract gave no evidence of
`esophageal or gastric varices. The stomach and second
`portion of the duodenum were displaced to the left
`and the hepatic flexure was displaced medially and
`inferiorly by the large liver. The colon was normal
`in appearance on roentgenogram. The skull was nor(cid:173)
`mal roentgenologically but there was some demineral(cid:173)
`ization of the femurs and of the bones of the hands.
`A punch biopsy specimen of the skin showed excess
`melanin deposited in the basal layer of the epithelium
`but no stainable iron. Although it was desired to
`carry out an aspiration biopsy of the liver, this was
`not done because of the prolonged prothrombin time,
`which was not significantly altered by vitamin K
`therapy. However, on a subsequent admission pri(cid:173)
`marily for dental extractions, a gastric biopsy speci(cid:173)
`men was obt11in1ed ann thte rteport ""'" a.• follows:
`
`Subjec t a nd Sc,
`
`Hemoglobin
`At ( %)
`
`Hemo(cid:173)
`globin
`F ( % l
`
`Diagnosis
`
`J.G . (propositus), M
`
`R.G. (sister), F
`S.A. (maternal au n1), F
`L.S. (maternal au.m). F
`
`1. l *
`Normalf
`Normalf
`Normalf
`
`44 .0
`
`I. 7
`l.9
`9 . 3
`
`T halassemia io1cr-
`mcdia
`Normal
`Normal
`Thala..-scroia minor
`
`* Determined by starch block electrophor~si.•.
`f Estimated by pa per electrophoresis.
`
`"section shows a segment of gastric mucosa, the
`glandular epithelium being diffusely and markedly
`infiltrated by golden brown pigment, which on spe(cid:173)
`cial stain is identified as iron."
`
`SPECIAL STUDIES AND COURSE
`Family Investigation. The patient's parents
`were born in Sicily and d ied in Buffalo, New
`York, where the patient was born. He was not
`aware of any history of anem ia, jaundice or other
`symptoms suggesting thalassemia in his parents
`or in any other member of the family. Few living
`members were accessible for testing, but two
`maternal aunts and the patient's 'only sibling,
`an unmarried sister, were seen (Table m). No
`abnormality was detected in their blood films,
`and the hemoglobin electrophoresis patterns
`were normal, with no increase in the A2 fraction.
`One aunt showed 9.3 per cent hemoglobin F by
`the alkali denaturation method [6], suggesting
`that she is a heterozygous carrier of a gene for
`the "high-F, normal-Ai" type of ,8-thalassemia.
`Treatment and Hospital Course. The initial
`d iagnosis was thalassemia major or intermedia,
`complicated by iron overload and associated
`cardiac failu re and hepatic disease. An addi(cid:173)
`tional complication was secondary megaloblastic
`anemia, thought to be due to relative folic acid
`deficiency, as confirmed by the subsequent re(cid:173)
`port of low serum levels of folic acid. At first
`treatment was d irected towards reversal of the
`cardiac failure by administration of digitalis
`and mercurial and thiazide diuretics. There was
`little improvement until a marked diuresis
`followed blood transfusion (3 units of packed red
`cells) and continued during treatment with
`hydrochlorothiazide and triampterene. The pa(cid:173)
`tient's initial weight was 143 pounds and it
`fell after diuresis to 105 pounds, remaining at
`about th is level over the subsequent months.
`The changes in hematologic findings are
`
`A M ERICAN .JOURNAL OF MEDICINE
`
`
`5 of 11
`
`Taro Pharmaceuticals, Ltd.
`Exhibit 1016
`
`

`

`Thalassemia Intermedia- Ba11nerman el al.
`
`481
`
`DEC.
`1964
`
`JIW
`1966
`
`FEB.
`
`MAR.
`
`JULY
`
`AUG.
`
`SEPT.
`
`OCT.
`
`DEC.
`
`Fm. 5. Hematologic changes in patient J.G. After blood transfusion, the reticulocyte
`count fell to 0.3 per cent. The bone marrow was initially megaloblastic and had become
`normoblastic by the seventh day after folic acid therapy was started. When folic acid ther(cid:173)
`apy was unintentionally. discontinued, there was a decrease in hematocrit and hemoglobin.
`
`shown in Figure 5. After blood transfusion the
`reticulocyte count fell from 10 per cent to only
`0. 3 per cent. In view of the patient's serious con(cid:173)
`dition, folic acid therapy (15 mg. orally daily)
`was started at this time. R eticulocytes increased
`to around the initial values and there was no
`further rise in hemoglobin and hematocrit.
`However, repeat bone marrow examination
`one week after folic acid therapy was started
`showed normoblastic erythropoiesis. Serum lac(cid:173)
`tic dehydrogenase (LDH) fell to 350 units.
`After the initial period of intensive investiga(cid:173)
`tion and treatment, there followed a longer per(cid:173)
`iod of continued observation and metabolic in(cid:173)
`vestigation during which the patient remained in
`the hospital. Although his general condition
`gradually improved, there was little apparent
`change or fluctuation in the degree of anemia
`and jaundice. During this relatively unchanging
`period, and subsequently, special studies were
`performed, including endocrinologic investiga(cid:173)
`tions, serial biochemical studies and observations
`on iron excretion, which will be detailed sub(cid:173)
`sequently. I n addition, an extensive investigation
`of hemoglobin and pyrrole metabolism was
`carried out by means of C14 labeling and will be
`described elsewhere.
`Endocrine Studies. Baseline twenty-four hour
`urinary 17-hydroxycorticosteroid excretion (17-
`
`v o L. 42, MARCH 196 7
`
`O H CS) was low and did not increase after
`administration of methopyrapone, 750 mg. every
`six hours for two days [8]. After stimulation with
`ACTH there was a definite but submaximal in(cid:173)
`crease, indicating limited adrenal responsiveness
`(Table rv). ACTH was not detectable in the
`blood [9).
`Serum protein-bound iodine was 2.8 µg. per
`100 ml. R adioactive iodine uptake was 13 per
`cent and increased to 23 per cent after admin(cid:173)
`istration of thyroid stimulating hormone, 10
`L U. daily for six days. Urinary gonadotropins
`were less than 6 mouse uterine units per twenty(cid:173)
`four hours. A standard oral glucose tolerance
`test was abnormal, with a blood glucose level
`of 260 mg. per 100 ml. two hours after the ad(cid:173)
`ministration of glucose. The disappearance rate
`after the rapid intravenous administration of
`glucose was 0.31 percent per minute [10).
`These studies were interpreted as showing
`deficiencies of anterior pituitary (thyroid stimu(cid:173)
`lating hormone, ACTH, gonadotropin) function,
`as well as primary thyroid, adrenal, pancreatic
`and possibly testicular functions.
`Biochemical Observations. During the period of
`study complete stool and urine collections were
`obtained continuously for more than seventy
`days. T otal fecal urobilinogen was estimated by
`a modification of the standard method [ 7 7]
`
`
`6 of 11
`
`Taro Pharmaceuticals, Ltd.
`Exhibit 1016
`
`

`

`482
`
`Thalassemia Intermedia-Bannerman el al.
`
`Tl\BL~ IV
`ENDOCRINE STUDIES
`
`Data
`
`Treat ment
`
`Results of Studies
`
`None
`None
`~etho pyrapone, 750 mg. every 6 hr.
`Methopyrapooe, 750 mg. every 6 hr.
`None
`ACTH, 40 units intravenously in 8 hr.
`ACTH, 40 units intravenously in 8 hr.
`
`None
`TSH, 10 l.U. / day
`
`Pituitary-adrenal function"'
`Day 1
`Day 2
`Day 3
`Day 4
`Day 5
`Day 6
`D ay 7
`Pituitary-thyroid function
`Day 11
`Days 12- 17
`Pancreatic function
`
`Pituitary-gonadal function
`
`Urinary excretion of 17-0HCS
`0.5 mg./ 24 hr.
`0.7 mg. / 24 hr.
`
`0.6 mg./24 hr.
`0.7 mg./24 hr.
`3.1 mg.;24 hr.
`9.5 mg./24 hr.
`1131 uptake
`Protein-bound iodine
`133
`2.8 µg. / 100 ml.
`233
`Oral glucose tolera nce test, 260 mg. ·3 at
`2 hr.
`Intravenous glucose tolerance test, disap(cid:173)
`pearance rate = 0.3%/min.
`Urinary gonadotropin = <6 mouse units/
`24 hr.
`
`* Plasma ACTH w as not detectable on day 1. Plasma cortisol w.u 8 µg. per cent before and t 7 µg. per cent after
`treatment with ACTH (40 units intravenously over an eight hour period on day 7).
`
`daily for seventy-seven days. AJl values were
`considerably elevated , ranging from 436 to 4,912
`mg. per day with a mean value of 1,744 mg.
`Urinary porphyrins were determined daily
`[12] and the excretion was 1,000 to 2,000 µg.
`per day with a mean value of 1,344 µg. The
`porphyrins isolated were composed of over 98
`per cent coproporphyrins (1 and m) with traces
`of uroporphyrin-m and possibly other inter(cid:173)
`mediate porphyrins as demonstrated by paper
`chromatography [13,74]. It was of great in(cid:173)
`terest that a considerable quantity of another
`pigment was also present in the urine and prob(cid:173)
`ably accounted for the invariable brown color
`which it showed. This pigment accompanied the
`porphyrins in extraction procedures, but could
`be separated by column chromatography. I t is
`thought to be a dipyrrole and investigations
`of its exact nature and metabolic role are con(cid:173)
`tinuing [75).
`Free erythrocrte protoporphyrin was also
`measured [76] at frequent intervals and con(cid:173)
`sistently showed slightly elevated values ranging
`from 30 to 200 µg. per 100 ml. of red cells, with
`a mean value of 63 µg. per 100 ml.
`Iron Excretion Studies. Urine was collected
`directly in iron-free acid-washed plastic beakers
`and collecting bottles, the volumes were meas(cid:173)
`ured and the iron content of an aliquot was
`determined by an acid digestion method [77].
`Two baseline twenty-four hour urinary iron
`
`values were 0.6 and 1.37 mg. (normal up to
`0.2 mg. per twenty-four hours). After admin(cid:173)
`istration of 500 mg. Desferal® (desferrioxamine)
`the value rose to 7 .0 mg. in the twenty-four hour
`period, and after 1,000 mg., to 17.7 mg. per
`twenty-four hours. Subsequently in the hospital,
`and after the patient's discharge from the hos(cid:173)
`pital, he was given a series of short courses,
`five to ten duys in duration, of Dcsfcral therapy,
`1,000 mg. per day by intramuscular injection.
`Urine was collected for several days, including
`the first and last days, for iron determinations
`and the values obtained were averaged to pro(cid:173)
`vide an estimate of the daily urine iron excretion
`for each five to ten day period. The quantity of
`iron excreted was greatly increased above base(cid:173)
`line values, rising as high as 79.0 mg. per day.
`The total amount of iron removed over several
`weeks was approximately 1.0 gm., but although
`the patient claimed subjective benefit during
`the courses, there was no objective evidence of
`improvement.
`Subsequent Course. The patient was discharged
`from the hospital in June 1965, taking digitalis,
`diuretics, folic acid, and hydrocortisone and
`thyroid hormone. He was able to carry on
`limited activity. However, a few weeks later he
`began to notice increasing diuresis and weak(cid:173)
`ness, and when seen was noted to be weaker
`than usual, mildly dehydrated and emitting an
`odor of acetone. His urine contained sugar and
`
`AMERICAN JOURNAL 01' ){ED!ClNE
`
`
`7 of 11
`
`Taro Pharmaceuticals, Ltd.
`Exhibit 1016
`
`

`

`Thalassemia Intermedia-Bannerman et al.
`
`483
`
`th e biood sugar vvas 568 mg. per cent. He was
`readmitted co the hospital and insulin was added
`to his medicines. The diabetes was stabilized
`with difficulty and, after further dental treat(cid:173)
`ment, he was again discharged in August 1965.
`On this occasion folic acid was not prescribed
`and it was subsequently noted on October
`12 that the film was more macrocytic and
`that there had been an apparent slight fall
`in hemoglobin and hematocrit (Fig. 5). Blood
`was drawn for serum folic acid determination
`(subsequently reported as low, Table u) and
`folic acid therapy was immediately reinstituted.
`
`COMMENTS
`This patient's lifetime encompasses the whole
`history of thalassemia, since he was born in
`1923, two years before Cooley described the
`major form and R ietti a minor form of the dis(cid:173)
`ease. The first diagnosis made in 1931 was "an
`atypical form of congenital hemolytic anemia."
`In l 932, when first seen by one of us, the diag(cid:173)
`nosis of Cooley's anemia was made. The m inor
`fon11 was not redescribed independently in the
`United States until 1940 (for historical refer(cid:173)
`ences, see Bannerman [781).
`\Ve have used the tern1 thalassernia inler(cid:173)
`mcdia to descr ibe the case, meaning a form of
`thalassemia intermediate in severity between the
`major and minor forms [79). The term has also
`been used to include some of the doubly heter(cid:173)
`ozygous states such as thalassemia-sickle cell
`disease [20]. The family study suggests that the
`patient could have received a gene for a {3
`form of thalassemia from the maternal side but,
`unfortunately, the family study is necessarily
`incomplete so that it is impossible to decide
`whether he might also have received another
`thalassemia gene from his father. I n fact, even if
`both parents of a patient also show evidence of
`thalassemia it may not be possible to determine
`with certainty whether the patient is homozy(cid:173)
`gous or heterozygous. Only a rare family ar(cid:173)
`rangement, one in which the suspected homozy(cid:173)
`gote is married to a normal subject, would allow
`a certain decision, since all of a homozygote's
`offspring should show evidence of the presence
`of the gene. Thus, although patients of this type
`are described as examples of the adult with
`Cooley's anemia [21-24], with the implication
`that they are homozygotes, this is rarely suscep(cid:173)
`tible to proof. We have tended to regard our
`patient as heterozygous because of his relatively
`benign earlier course, but he has shown many of
`
`VOi. . . 42, MAR C H 1967
`
`the features of Cooley's anemia, including eryth(cid:173)
`roblastosis (even before splenectom) ), inter(cid:173)
`mittent jaundice and splenomegaly. The hemo(cid:173)
`globin pattern, too, would indicate this diag(cid:173)
`nosis. H e showed only m inor bone changes at
`the age of forty-one.
`The next question that arises is why his con(cid:173)
`dition became so much worse at the: age of
`forty since he had had relatively minor symp(cid:173)
`toms after splenectomy at six years of age despite
`hemoglobin levels apparently varying f'rom 7.6
`to 12.9 gm. per 100 ml. \ Ve have explained this
`as a cumulat ive effect of increasing iron overload
`on many organs, leading to concurrent cardiac
`failure, hepatic dysfunction and multiple endo(cid:173)
`crine deficie ncies. Some degree of coronary ar(cid:173)
`tery atherosclerosis could well have contributed,
`as did the complication of folic acid deficiency
`with further slight fall in the hemoglobin level
`to 6.0 gm. per 100 ml.
`Relative folic acid deficiency, sometimes with
`megaloblastic changes, has been reported previ(cid:173)
`ously in thalassemia major [25-28), intermedia
`[29) and minor during the additional stress of
`pregnancy [30]. T he elevated serum levels of
`lactic dehydrogenase (LDH) in this ~ituation
`have been a ttributed to inc.-eased desti ucliu11 uf
`red cell precursors in the bone marrovv [37 ].
`Severe iron overload was demonstrated by
`iron deposition in the gastric mucosa on biopsy
`and by the urinary iron excretion induced by des(cid:173)
`ferrioxamine therapy, and the skin pigmentation
`and high saturation of the iron-binding capacity
`are consistent with this diagnosis. Although
`a precise relationship between desferrioxamine
`response and body iron load has not yet been
`documented, a rough proportionality probably
`exists, and the results in this patient were in the
`range expected in idiopathic hernochroma tosis
`and in severe secondary he rnochrornatosis due
`to blood transfusion [32- 35]. The few blood
`transfusions given at the time of splenectomy
`would not account for iron overload. The iron
`medication, given for an unknown total period
`but probably for several years, provided a daily
`oral dose of 500 mg. iron. Patients with thalas(cid:173)
`semia continue to absorb iron eYen when they
`are already iron laden [36]. If we assume that
`only 5 per cent of the iron in medications was
`absorbed, it could have led to iron accumulation
`in the body at the rate of 10 gm. per year. Fur(cid:173)
`thermore, the patient deliberately chose iron(cid:173)
`rich foods, such as liver, for many years of his
`life. T hese sourct:s, medication and diet, are
`
`
`8 of 11
`
`Taro Pharmaceuticals, Ltd.
`Exhibit 1016
`
`

`

`484
`
`Thalassemia Intermedia-Bannerman et al.
`
`assumed to be the causes of his serious iron load.
`The possible danger of administering iron to a
`patient of this type is evident.
`Although the unavoidable accumulation of
`iron in patients given t ransfusions is well known
`and is regarded as a major cause of serious com(cid:173)
`plications [3-5,37], reports of its occurrence in
`patients with thalassemia who have received no
`or few transfusions are uncommon [7,38- 40].
`Some pathologists are skeptical of the role of
`iron overload in producing tissue damage and
`point to the paucit y of animal experiments which
`can be inter preted as showing this effect [47,42] .
`It is clear, too,

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket